Novel molecular approaches for improving enzymatic and nonenzymatic detoxification of 4-hydroxynonenal: Toward the discovery of a novel class of bioactive compounds

Free Radical Biology and Medicine

Volumn 69, Issue , 2014, Pages 145-156

  Aldini, Giancarlo ^a   Carini, Marina ^a   Yeum, Kyung Jin ^b   Vistoli, Giulio ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b Konkuk University   (South Korea)

Author keywords

4 Hydroxy trans 2 nonenal; Advanced lipoxidation end products; Carnosine; Free radicals; Sequestering agents

Indexed keywords

4-HYDROXY-TRANS-2-NONENAL; ADVANCED LIPOXIDATION END PRODUCTS; CARNOSINE; FREE RADICALS; SEQUESTERING AGENTS;

ADVANCED OXIDATION PROTEIN PRODUCTS; ALDEHYDES; CARNOSINE; FATTY ACIDS, OMEGA-6; FREE RADICALS; HUMANS; LIPID PEROXIDATION; METABOLIC DETOXICATION, PHASE I;

EID: 84893822259     PISSN: 08915849     EISSN: 18734596     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2014.01.017     Document Type: Review

References (106)

1. H. Esterbauer, R.J. Schaur, and H. Zollner Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes Free Radic. Biol. Med. 11 1991 81 128 (Pubitemid 121003917)
2. R.M. LoPachin, T. Gavin, D.R. Petersen, and D.S. Barber Molecular mechanisms of 4-hydroxy-2-nonenal and acrolein toxicity: nucleophilic targets and adduct formation Chem. Res. Toxicol. 22 2009 1499 1508
3. R.J. Schaur Basic aspects of the biochemical reactivity of 4-hydroxynonenal Mol. Aspects Med. 24 2003 149 159 (Pubitemid 36945015)
4. J.A. Doorn, and D.R. Petersen Covalent modification of amino acid nucleophiles by the lipid peroxidation products 4-hydroxy-2-nonenal and 4-oxo-2-nonenal Chem. Res. Toxicol. 15 2002 1445 1450 (Pubitemid 35364906)
5. R.M. Lopachin, B.C. Geohagen, and T. Gavin Synaptosomal toxicity and nucleophilic targets of 4-hydroxy-2-nonenal Toxicol. Sci. 107 2009 171 181
6. P.A. Grimsrud, H. Xie, T.J. Griffin, and D.A. Bernlohr Oxidative stress and covalent modification of protein with bioactive aldehydes J. Biol. Chem. 283 2008 21837 21841
7. S. Boncel, K. Saletra, B. Hefczyc, and K. Walczak Michael-type addition of azoles of broad-scale acidity to methyl acrylate Beilstein J. Org. Chem. 7 2011 173 178
8. A.L. Isom, S. Barnes, L. Wilson, M. Kirk, L. Coward, and V. Darley-Usmar Modification of cytochrome c by 4-hydroxy-2-nonenal: evidence for histidine, lysine, and arginine-aldehyde adducts J. Am. Soc. Mass Spectrom. 15 2004 1136 1147 (Pubitemid 38970057)
9. J. Zhao, J. Chen, H. Zhu, and Y.L. Xiong Mass spectrometric evidence of malonaldehyde and 4-hydroxynonenal adductions to radical-scavenging soy peptides J. Agric. Food Chem. 60 2012 9727 9736
10. H. Zhang, N. Court, and H.J. Forman Submicromolar concentrations of 4-hydroxynonenal induce glutamate cysteine ligase expression in HBE1 cells Redox Rep. 12 2007 101 106 (Pubitemid 46210366)
11. G. Cohen, Y. Riahi, O. Shamni, M. Guichardant, C. Chatgilialoglu, C. Ferreri, N. Kaiser, and S. Sasson Role of lipid peroxidation and PPAR-δ in amplifying glucose-stimulated insulin secretion Diabetes 60 2011 2830 2842
12. A. Ishikado, Y. Nishio, K. Morino, S. Ugi, H. Kondo, T. Makino, A. Kashiwagi, and H. Maegawa Low concentration of 4-hydroxy hexenal increases heme oxygenase-1 expression through activation of Nrf2 and antioxidative activity in vascular endothelial cells Biochem. Biophys. Res. Commun. 402 2010 99 104
13. T. Ishii, K. Itoh, E. Ruiz, D.S. Leake, H. Unoki, M. Yamamoto, and G.E. Mann Role of Nrf2 in the regulation of CD36 and stress protein expression in murine macrophages: activation by oxidatively modified LDL and 4-hydroxynonenal Circ. Res. 94 2004 609 616 (Pubitemid 38387743)
14. Z.H. Chen, Y. Saito, Y. Yoshida, A. Sekine, N. Noguchi, and E. Niki 4-Hydroxynonenal induces adaptive response and enhances PC12 cell tolerance primarily through induction of thioredoxin reductase 1 via activation of Nrf2 J. Biol. Chem. 280 2005 41921 41927 (Pubitemid 43023161)
15. Y. Huang, W. Li, and A.N. Kong Anti-oxidative stress regulator NF-E2-related factor 2 mediates the adaptive induction of antioxidant and detoxifying enzymes by lipid peroxidation metabolite 4-hydroxynonenal Cell Biosci. 2 2012 40
16. H.Q. Zhang, H.L. Liu, D.A. Dickinson, R.M. Liu, E.M. Postlethwait, Y. Laperche, and H.J. Forman γ-Glutamyl transpeptidase is induced by 4-hydroxynonenal via EpRE/Nrf2 signaling in rat epithelial type II cells Free Radic. Biol. Med. 40 2006 1281 1292 (Pubitemid 44316497)
17. H.J. Forman Reactive oxygen species and alpha,beta-unsaturated aldehydes as second messengers in signal transduction Ann. N. Y. Acad. Sci. 1203 2010 35 44
18. Y. Riahi, G. Cohen, O. Shamni, and S. Sasson Signaling and cytotoxic functions of 4-hydroxyalkenals Am. J. Physiol. Endocrinol. Metab. 299 2010 E879 E886
19. G. Poli, R.J. Schaur, W.G. Siems, and G. Leonarduzzi 4-Hydroxynonenal: a membrane lipid oxidation product of medicinal interest Med. Res. Rev. 28 2008 569 631 (Pubitemid 351842143)
20. M. Shoeb, N.H. Ansari, S.K. Srivastava, and K.V. Ramana 4-Hydroxynonenal in the pathogenesis and progression of human diseases Curr. Med. Chem. 21 2013 230 237
21. I. Dalle-Donne, G. Aldini, M. Carini, R. Colombo, R. Rossi, and A. Milzani Protein carbonylation, cellular dysfunction, and disease progression J. Cell. Mol. Med. 10 2006 389 406 (Pubitemid 44870187)
22. K.H. Ingram, H. Hill, D.R. Moellering, B.G. Hill, C. Lara-Castro, B. Newcomer, L.J. Brandon, C.P. Ingalls, M. Penumetcha, J.C. Rupp, and W.T. Garvey Skeletal muscle lipid peroxidation and insulin resistance in humans J. Clin. Endocrinol. Metab. 97 2012 E1182 E1186
23. S.P. Singh, M. Niemczyk, D. Saini, Y.C. Awasthi, L. Zimniak, and P. Zimniak Role of the electrophilic lipid peroxidation product 4-hydroxynonenal in the development and maintenance of obesity in mice Biochemistry 47 2008 3900 3911 (Pubitemid 351431379)
24. N.J. Pillon, R.E. Vella, L. Souleere, M. Becchi, M. Lagarde, and C.O. Soulage Structural and functional changes in human insulin induced by the lipid peroxidation byproducts 4-hydroxy-2-nonenal and 4-hydroxy-2-hexenal Chem. Res. Toxicol. 24 2011 752 762
25. N.J. Pillon, M.L. Croze, R.E. Vella, L. Soulère, M. Lagarde, and C.O. Soulage The lipid peroxidation by-product 4-hydroxy-2-nonenal (4-HNE) induces insulin resistance in skeletal muscle through both carbonyl and oxidative stress Endocrinology 153 2012 2099 2111
26. I. Miwa, N. Ichimura, M. Sugiura, Y. Hamada, and S. Taniguchi Inhibition of glucose-induced insulin secretion by 4-hydroxy-2-nonenal and other lipid peroxidation products Endocrinology 141 2000 2767 2772 (Pubitemid 32250437)
27. G. Leonarduzzi, F. Robbesyn, and G. Poli Signaling kinases modulated by 4-hydroxynonenal Free Radic. Biol. Med. 37 2004 1694 1702 (Pubitemid 39445371)
28. P.A. Grimsrud, M.J. Picklo, T.J. Griffin, and D.A. Bernlohr Carbonylation of adipose proteins in obesity and insulin resistance: identification of adipocyte fatty acid-binding protein as a cellular target of 4-hydroxynonenal Mol. Cell. Proteomics 6 2007 624 637 (Pubitemid 46630095)
29. K. Dasuri, P. Ebenezer, S.O. Fernandez-Kim, L. Zhang, Z. Gao, A.J. Bruce-Keller, L.R. Freeman, and J.N. Keller Role of physiological levels of 4-hydroxynonenal on adipocyte biology: implications for obesity and metabolic syndrome Free Radic. Res. 47 2013 8 19
30. X. Zhang, Z. Wang, J. Li, D. Gu, S. Li, C. Shen, and Z. Song Increased 4-hydroxynonenal formation contributes to obesity-related lipolytic activation in adipocytes PLoS One 8 2013 e70663
31. S. Ylä-Herttuala, W. Palinski, M.E. Rosenfeld, S. Parthasarathy, T.E. Carew, S. Butler, J.L. Witztum, and D. Steinberg Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man J. Clin. Invest. 84 1989 1086 1095 (Pubitemid 19247577)
32. G. Jürgens, Q. Chen, H. Esterbauer, S. Mair, G. Ledinski, and H.P. Dinges Immunostaining of human autopsy aortas with antibodies to modified apolipoprotein B and apoprotein(a) Arterioscler. Thromb. 13 1993 1689 1699 (Pubitemid 23328490)
33. H.F. Hoff, J. O Neil, G.M. Chisolm, T.B. Cole, O. Quehenberger, H. Esterbauer, and G. Jürgens Modification of low density lipoprotein with 4-hydroxynonenal induces uptake by macrophages Arteriosclerosis 9 1989 538 549 (Pubitemid 19184488)
34. Y.M. Go, P.J. Halvey, J.M. Hansen, M. Reed, J. Pohl, and D.P. Jones Reactive aldehyde modification of thioredoxin-1 activates early steps of inflammation and cell adhesion Am. J. Pathol. 171 2007 1670 1681 (Pubitemid 350158327)
35. R. Vatsyayan, H. Kothari, U.R. Pendurthi, and L.V. Rao 4-Hydroxy-2-nonenal enhances tissue factor activity in human monocytic cells via p38 mitogen-activated protein kinase activation-dependent phosphatidylserine exposure Arterioscler. Thromb. Vasc. Biol. 33 2013 1601 1611
36. D.L. Carbone, J.A. Doorn, Z. Kiebler, and D.R. Petersen Cysteine modification by lipid peroxidation products inhibits protein disulfide isomerase Chem. Res. Toxicol. 18 2005 1324 1331 (Pubitemid 41174583)
37. C. Muller, J. Bandemer, C. Vindis, C. Camaré, E. Mucher, F. Guéraud, P. Larroque-Cardoso, C. Bernis, N. Auge, R. Salvayre, and A. Negre-Salvayre Protein disulfide isomerase modification and inhibition contribute to ER stress and apoptosis induced by oxidized low density lipoproteins Antioxid. Redox Signaling 18 2013 731 742
38. M. Perluigi, R. Coccia, and D.A. Butterfield 4-Hydroxy-2-nonenal, a reactive product of lipid peroxidation, and neurodegenerative diseases: a toxic combination illuminated by redox proteomics studies Antioxid. Redox Signaling 17 2012 1590 1609
39. R. Sultana, M. Perluigi, and D. Allan Butterfield Lipid peroxidation triggers neurodegeneration: a redox proteomics view into the Alzheimer disease brain Free Radic. Biol. Med. 62 2013 157 169
40. J.T. Keeney, A.M. Swomley, S. Förster, J.L. Harris, R. Sultana, and D.A. Butterfield Apolipoprotein A-I: insights from redox proteomics for its role in neurodegeneration Proteomics Clin. Appl. 7 2013 109 122
41. C.D. Aluise, K. Rose, M. Boiani, M.L. Reyzer, J.D. Manna, K. Tallman, N.A. Porter, and L.J. Marnett Peptidyl-prolyl cis/trans-isomerase A1 (Pin1) is a target for modification by lipid electrophiles Chem. Res. Toxicol. 26 2013 270 279
42. J. Frackowiak, B. Mazur-Kolecka, N.C. Schanen, W.T. Brown, and J. Wegiel The link between intraneuronal N-truncated amyloid-β peptide and oxidatively modified lipids in idiopathic autism and dup(15q11.2-q13)/autism Acta Neuropathol. Commun. 1 2013 61
43. A. Pecorelli, S. Leoncini, C. De Felice, C. Signorini, C. Cerrone, G. Valacchi, L. Ciccoli, and J. Hayek Non-protein-bound iron and 4-hydroxynonenal protein adducts in classic autism Brain Dev. 35 2013 146 154
44. A. Pecorelli, L. Ciccoli, C. Signorini, S. Leoncini, A. Giardini, M. D Esposito, S. Filosa, J. Hayek, C. De Felice, and G. Valacchi Increased levels of 4HNE-protein plasma adducts in Rett syndrome Clin. Biochem. 44 2011 368 371
45. C. Signorini, C. De Felice, T. Durand, C. Oger, J.M. Galano, S. Leoncini, A. Pecorelli, G. Valacchi, L. Ciccoli, and J. Hayek Isoprostanes and 4-hydroxy-2-nonenal: markers or mediators of disease? Focus on Rett syndrome as a model of autism spectrum disorder Oxid. Med. Cell. Longevity 2013 2013 343824
46. S. Lee, T. Oe, J. Arora, and I. Blair Analysis of Fe(II)-mediated decomposition of a linoleic acid-derived lipid hydroperoxide by liquid chromatography/mass spectrometry J. Mass Spectrom. 40 2005 661 668 (Pubitemid 40733324)
47. M.H. Kang, M. Naito, K. Sakai, K. Uchida, and T. Osawa Mode of action of sesame lignans in protecting low-density lipoprotein against oxidative damage in vitro Life Sci. 66 2000 161 171 (Pubitemid 30025463)
48. K. De, K. Roy, and C. Sengupta Inhibition of lipid peroxidation induced by hydroxyprogesterone caproate by some conventional antioxidants in goat liver homogenates Acta Pol. Pharm 64 2007 201 210 (Pubitemid 351360421)
49. M. Zhang, M. Shoeb, P. Liu, T. Xiao, D. Hogan, I.G. Wong, G.A. Campbell, and N.H. Ansari Topical metal chelation therapy ameliorates oxidation-induced toxicity in diabetic cataract J. Toxicol. Environ. Health A 74 2011 380 391
50. S. Devaraj, S. Mathur, A. Basu, H.H. Aung, V.T. Vasu, S. Meyers, and I. Jialal A dose-response study on the effects of purified lycopene supplementation on biomarkers of oxidative stress J. Am. Coll. Nutr. 27 2008 267 273
51. C.L. Miranda, R.L. Reed, H.C. Kuiper, S. Alber, and J.F. Stevens Ascorbic acid promotes detoxification and elimination of 4-hydroxy-2(E)-nonenal in human monocytic THP-1 cells Chem. Res. Toxicol. 22 2009 863 874
52. H. Yoshida, H. Yanai, Y. Namiki, K. Fukatsu-Sasaki, N. Furutani, and N. Tada Neuroprotective effects of edaravone: a novel free radical scavenger in cerebrovascular injury CNS Drug Rev. 12 2006 9 20 (Pubitemid 44133577)
53. S. Zhou, G. Yu, L. Chi, J. Zhu, W. Zhang, Y. Zhang, and L. Zhang Neuroprotective effects of edaravone on cognitive deficit, oxidative stress and tau hyperphosphorylation induced by intracerebroventricular streptozotocin in rats Neurotoxicology 38C 2013 136 145
54. N. Zhang, M. Komine-Kobayashi, R. Tanaka, M. Liu, Y. Mizuno, and T. Urabe Edaravone reduces early accumulation of oxidative products and sequential inflammatory responses after transient focal ischemia in mice brain Stroke 36 2005 2220 2225 (Pubitemid 41429250)
55. H. Xi, M. Akishita, K. Nagai, W. Yu, H. Hasegawa, M. Eto, K. Kozaki, and K. Toba Potent free radical scavenger, edaravone, suppresses oxidative stress-induced endothelial damage and early atherosclerosis Atherosclerosis 191 2007 281 289 (Pubitemid 46400711)
56. G. Aldini, G. Vistoli, L. Regazzoni, M.C. Benfatto, I. Bettinelli, and M. Carini Edaravone inhibits protein carbonylation by a direct carbonyl-scavenging mechanism: focus on reactivity, selectivity, and reaction mechanisms Antioxid. Redox Signaling 12 2010 381 392
57. S. Coimbra, E. Castro, P. Rocha-Pereira, I. Rebelo, S. Rocha, and A. Santos-Silva The effect of green tea in oxidative stress Clin. Nutr. 25 2006 790 796 (Pubitemid 44426430)
58. A. Basu, K. Sanchez, M.J. Leyva, M. Wu, N.M. Betts, C.E. Aston, and T.J. Lyons Green tea supplementation affects body weight, lipids, and lipid peroxidation in obese subjects with metabolic syndrome J. Am. Coll. Nutr. 29 2010 31 40
59. A. Basu, E.D. Newman, A.L. Bryant, T.J. Lyons, and N.M. Betts Pomegranate polyphenols lower lipid peroxidation in adults with type 2 diabetes but have no effects in healthy volunteers: a pilot study J. Nutr. Metab 2013 2013 708381
60. R. Rodrigo, A. Miranda, and L. Vergara Modulation of endogenous antioxidant system by wine polyphenols in human disease Clin. Chim. Acta 412 2011 410 424
61. H.C. Kuiper, and J.F. Stevens LC-MS/MS quantitation of mercapturic acid conjugates of lipid peroxidation products as markers of oxidative stress Curr. Protoc. Toxicol. 2011 (Chap. 17:Unit 17.14.12)
62. B. Testa, and S.D. Krämer The biochemistry of drug metabolism - an introduction. Part 4. Reactions of conjugation and their enzymes Chem. Biodiversity 5 2008 2171 2336
63. F.I. Zuniga, D. Loi, K.H. Ling, and D.D. Tang-Liu Idiosyncratic reactions and metabolism of sulfur-containing drugs Expert Opin. Drug Metab. Toxicol. 8 2012 467 485
64. D. Tahmassebi Substituent effects on the stability of carbodiimides J. Chem. Soc. Perkin Trans. 2 4 2001 613 617
65. M. Arakawa, N. Ushimaru, N. Osada, T. Oda, K. Ishige, and Y. Ito N-acetylcysteine selectively protects cerebellar granule cells from 4-hydroxynonenal-induced cell death Neurosci. Res. 55 2006 255 263 (Pubitemid 43766414)
66. M. Arakawa, and Y. Ito N-acetylcysteine and neurodegenerative diseases: basic and clinical pharmacology Cerebellum 6 2007 308 314 (Pubitemid 350179062)
67. Y. Al-Abed, and R. Bucala Efficient scavenging of fatty acid oxidation products by aminoguanidine Chem. Res. Toxicol. 10 1997 875 879 (Pubitemid 27350046)
68. M.D. Neely, L. Zimmerman, M.J. Picklo, J.J. Ou, C.R. Morales, and K.S. Montine Amaranth, V.; Montine, T. J. Congeners of N(α)-acetyl-l-cysteine but not aminoguanidine act as neuroprotectants from the lipid peroxidation product 4-hydroxy-2-nonenal Free Radic. Biol. Med. 29 2000 1028 1036
69. P.J. Thornalley, A. Yurek-George, and O.K. Argirov Kinetics and mechanism of the reaction of aminoguanidine with the alpha-oxoaldehydes glyoxal, methylglyoxal, and 3-deoxyglucosone under physiological conditions Biochem. Pharmacol. 60 2000 55 65 (Pubitemid 30243085)
70. P.J. Thornalley Use of aminoguanidine (Pimagedine) to prevent the formation of advanced glycation endproducts Arch. Biochem. Biophys 419 2003 31 40 (Pubitemid 37279141)
71. V. Amarnath, K. Amarnath, S. Davies, and L.J. Roberts Pyridoxamine: an extremely potent scavenger of 1,4-dicarbonyls Chem. Res. Toxicol. 17 2004 410 415 (Pubitemid 38375066)
72. J.M. Onorato, A.J. Jenkins, S.R. Thorpe, and J.W. Baynes Pyridoxamine, an inhibitor of advanced glycation reactions, also inhibits advanced lipoxidation reactions: mechanism of action of pyridoxamine J. Biol. Chem. 275 2000 21177 21184 (Pubitemid 30481811)
73. T.O. Metz, N.L. Alderson, M.E. Chachich, S.R. Thorpe, and J.W. Baynes Pyridoxamine traps intermediates in lipid peroxidation reactions in vivo: evidence on the role of lipids in chemical modification of protein and development of diabetic complications J. Biol. Chem. 278 2003 42012 42019 (Pubitemid 37310465)
74. P.A. Voziyan, and B.G. Hudson Pyridoxamine as a multifunctional pharmaceutical: targeting pathogenic glycation and oxidative damage Cell Mol. Life Sci. 62 2005 1671 1681 (Pubitemid 41176049)
75. B. Shepler, C. Nash, C. Smith, A. DiMarco, J. Petty, and S. Szewciw Update on potential drugs for the treatment of diabetic kidney disease Clin. Ther. 34 2012 1237 1246
76. G. Aldini, G. Vistoli, M. Stefek, N. Chondrogianni, T. Grune, J. Sereikaite, I. Sadowska-Bartosz, and G. Bartosz Molecular strategies to prevent, inhibit, and degrade advanced glycoxidation and advanced lipoxidation end products Free Radic. Res. 47 Suppl. 1 2013 93 137
77. M. Maheshwari, J.K. Roberts, B. Desutter, K.T. Duong, J. Tingling, J.N. Fawver, H.E. Schall, M. Kahle, and I.V. Murray Hydralazine modifies Aβ fibril formation and prevents modification by lipids in vitro Biochemistry 49 2010 10371 10380
78. C. Vindis, I. Escargueil-Blanc, M. Elbaz, B. Marcheix, M.H. Grazide, K. Uchida, R. Salvayre, and A. Nègre-Salvayre Desensitization of platelet-derived growth factor receptor-beta by oxidized lipids in vascular cells and atherosclerotic lesions: prevention by aldehyde scavengers Circ. Res. 98 2006 785 792
79. P.C. Burcham, L.M. Kaminskas, D. Tan, and S.M. Pyke Carbonyl-scavenging drugs & protection against carbonyl stress-associated cell injury Mini Rev. Med. Chem. 8 2008 319 330 (Pubitemid 351606774)
80. G. Vistoli, M. Orioli, A. Pedretti, L. Regazzoni, R. Canevotti, G. Negrisoli, M. Carini, and G. Aldini Design, synthesis, and evaluation of carnosine derivatives as selective and efficient sequestering agents of cytotoxic reactive carbonyl species ChemMedChem 4 2009 967 975
81. T. Münzel, S. Kurz, S. Rajagopalan, M. Thoenes, W.R. Berrington, J.A. Thompson, B.A. Freeman, and D.G. Harrison Hydralazine prevents nitroglycerin tolerance by inhibiting activation of a membrane-bound NADH oxidase: a new action for an old drug J. Clin. Invest. 98 1996 1465 1470 (Pubitemid 26322073)
82. A.A. Boldyrev, G. Aldini, and W. Derave Physiology and pathophysiology of carnosine Physiol. Rev. 93 2013 1803 1845
83. G. Aldini, P. Granata, and M. Carini Detoxification of cytotoxic alpha,beta-unsaturated aldehydes by carnosine: characterization of conjugated adducts by electrospray ionization tandem mass spectrometry and detection by liquid chromatography/mass spectrometry in rat skeletal muscle J. Mass Spectrom. 37 2002 1219 1228 (Pubitemid 36041609)
84. M. Colzani, A. Criscuolo, M. De Maddis, D. Garzon, K.-J. Yeum, G. Vistoli, M. Carini, and G. Aldini A novel high resolution MS approach for the screening of 4-hydroxy-trans-2-nonenal sequestering agents J. Pharm. Biomed. Anal. 91 2013 108 118
85. G. Vistoli, V. Straniero, A. Pedretti, L. Fumagalli, C. Bolchi, M. Pallavicini, E. Valoti, and B. Testa Predicting the physicochemical profile of diastereoisomeric histidine-containing dipeptides by property space analysis Chirality 24 2012 566 576
86. M. Orioli, G. Aldini, G. Beretta, R.M. Facino, and M. Carini LC-ESI-MS/MS determination of 4-hydroxy-trans-2-nonenal Michael adducts with cysteine and histidine-containing peptides as early markers of oxidative stress in excitable tissues J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 827 2005 109 118 (Pubitemid 41551604)
87. S.P. Baba, J.D. Hoetker, M. Merchant, J.B. Klein, J. Cai, O.A. Barski, D.J. Conklin, and A. Bhatnagar Role of aldose reductase in the metabolism and detoxification of carnosine-acrolein conjugates J. Biol. Chem. 288 2013 28163 28179
88. G. Aldini, M. Orioli, G. Rossoni, F. Savi, P. Braidotti, G. Vistoli, K.J. Yeum, G. Negrisoli, and M. Carini The carbonyl scavenger carnosine ameliorates dyslipidaemia and renal function in Zucker obese rats J. Cell. Mol. Med. 15 2011 1339 1354
89. K. Nagai, M. Tanida, A. Niijima, N. Tsuruoka, Y. Kiso, Y. Horii, J. Shen, and N. Okumura Role of l-carnosine in the control of blood glucose, blood pressure, thermogenesis, and lipolysis by autonomic nerves in rats: involvement of the circadian clock and histamine Amino Acids 43 2012 97 109
90. O.A. Barski, Z. Xie, S.P. Baba, S.D. Sithu, A. Agarwal, J. Cai, A. Bhatnagar, and S. Srivastava Dietary carnosine prevents early atherosclerotic lesion formation in apolipoprotein E-null mice Arterioscler. Thromb. Vasc. Biol. 33 2013 1162 1170
91. M. Orioli, G. Vistoli, L. Regazzoni, A. Pedretti, A. Lapolla, G. Rossoni, R. Canevotti, L. Gamberoni, M. Previtali, M. Carini, and G. Aldini Design, synthesis, ADME properties, and pharmacological activities of beta-alanyl-D-histidine (D-carnosine) prodrugs with improved bioavailability ChemMedChem 6 2011 1269 1282
92. S. Menini, C. Iacobini, C. Ricci, A. Scipioni, C.B. Fantauzzi, A. Giaccari, E. Salomone, R. Canevotti, A. Lapolla, M. Orioli, G. Aldini, and G. Pugliese d-Carnosine octylester attenuates atherosclerosis and renal disease in ApoE null mice fed a Western diet through reduction of carbonyl stress and inflammation Br. J. Pharmacol. 166 2012 1344 1356
93. L.M. Balogh, and W.M. Atkins Interactions of glutathione transferases with 4-hydroxynonenal Drug Metab. Rev. 43 2011 165 178
94. J. Alary, F. Gueraud, and J.-P. Cravedi Fate of 4-hydroxynonenal in vivo: disposition and metabolic pathways Mol. Aspects Med. 24 2003 177 187 (Pubitemid 36945018)
95. J.M. Guo, A.J. Liu, P. Zang, W.Z. Dong, L. Ying, W. Wang, P. Xu, X.R. Song, J. Cai, S.Q. Zhang, J.L. Duan, J.L. Mehta, and D.F. Su ALDH2 protects against stroke by clearing 4-HNE Cell Res. 23 2013 915 930
96. Q. Yuan, S. Hong, S. Han, L. Zeng, F. Liu, G. Ding, Y. Kang, J. Mao, M. Cai, Y. Zhu, and Q.X. Wang Preconditioning with physiological levels of ethanol protect kidney against ischemia/reperfusion injury by modulating oxidative stress PLoS One 6 2011 e25811
97. E.N. Churchill, M.H. Disatnik, and D. Mochly-Rosen Time-dependent and ethanol-induced cardiac protection from ischemia mediated by mitochondrial translocation of varepsilonPKC and activation of aldehyde dehydrogenase 2 J. Mol. Cell. Cardiol. 46 2009 278 284
98. M. Miyamae, K. Kaneda, N. Domae, and V.M. Figueredo Cardioprotection by regular ethanol consumption: potential mechanisms and clinical application Curr. Drug Abuse Rev. 3 2010 39 48
99. C.H. Chen, G.R. Budas, E.N. Churchill, M.H. Disatnik, T.D. Hurley, and D. Mochly-Rosen Activation of aldehyde dehydrogenase-2 reduces ischemic damage to the heart Science 321 2008 1493 1495
100. G.R. Budas, M.H. Disatnik, C.H. Chen, and D. Mochly-Rosen Activation of aldehyde dehydrogenase 2 (ALDH2) confers cardioprotection in protein kinase C epsilon (PKCvarepsilon) knockout mice J. Mol. Cell. Cardiol. 48 2010 757 764
101. J.A. Doorn, T.D. Hurley, and D.R. Petersen Inhibition of human mitochondrial aldehyde dehydrogenase by 4-hydroxynon-2-enal and 4-oxonon-2-enal Chem. Res. Toxicol. 19 2006 102 110 (Pubitemid 43185467)
102. L. He, B. Liu, Z. Dai, H.F. Zhang, Y.S. Zhang, X.J. Luo, Q.L. Ma, and J. Peng Alpha lipoic acid protects heart against myocardial ischemia-reperfusion injury through a mechanism involving aldehyde dehydrogenase 2 activation Eur. J. Pharmacol. 678 2012 32 38
103. J.S. Lee, and Y.J. Surh Nrf2 as a novel molecular target for chemoprevention Cancer Lett. 224 2005 171 184
104. D.M. Miller, I.N. Singh, J.A. Wang, and E.D. Hall Administration of the Nrf2-ARE activators sulforaphane and carnosic acid attenuates 4-hydroxy-2-nonenal-induced mitochondrial dysfunction ex vivo Free Radic. Biol. Med. 57 2013 1 9
105. A.J. Wilson, J.K. Kerns, J.F. Callahan, and C.J. Moody Keap calm, and carry on covalently J. Med. Chem. 56 2013 7463 7476
106. K. Yang, D. Qiang, S. Delaney, R. Mehta, W.R. Bruce, and P.J. O Brien Differences in glyoxal and methylglyoxal metabolism determine cellular susceptibility to protein carbonylation and cytotoxicity Chem.-Biol. Interact. 191 2011 322 329